Diabetes Drug Recalled Due to High Levels of Substance that ‘Could Cause Cancer,’ FDA Says

Marksans Pharma Limited had expanded its voluntary recall of Metformin Hydrochloride Extended-Release Tablets

A drug commonly used to treat Type 2 diabetes has been recalled due to cancer concerns.

This week, the Food and Drug Administration announced that Marksans Pharma Limited had expanded its voluntary recall of Metformin Hydrochloride Extended-Release Tablets. An additional 76 unexpired lots were determined to possibly contain levels of NDMA — which is classified by the FDA as a “probable human carcinogen (a substance that could cause cancer)” — that exceed acceptable daily amounts.

The recall applies to Metformin tablets in 500 mg and 750 mg packages, which are both off-white and embossed with either ‘101’ or ‘102’ on one side, and are plain on the other side. More detailed information can be found on the FDA’s website.

Read entire article.